Nifty

:

25665.60

Sensex

:

83382.71

-66.70 (-0.26%)
-244.98 (-0.29%)

Login

Nifty
Sensex

:
:

25665.60
83382.71

-66.70 (-0.26%)
-244.98 (-0.29%)

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

Rating :

44/99

BSE: 539872 | NSE: BAJAJHCARE

Watchlist

NSE BSE

394.15

14-Jan-2026

Open
High
Low
Previous Close

384.95
399.7
383.3
385.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

136748
53940879.1
745
379.1

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,243.91
24.30
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,451.13
0.25%
2.56

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

10.48
-3.75
-5.64

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.64
-9.55
-5.83

PAT CAGR (%)

10 Years
5 Years
3 Years

18.00
-12.38
-12.25

P:E (Median)

8 Years
5 Years
3 Years

16.36
14.96
20.43

P:BV (Average)

8 Years
5 Years
3 Years

3.40
3.31
3.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.71
12.82
15.41

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 147.92 133.09 11.14% 148.84 132.25 12.54% 154.47 133.90 15.36% 122.79 108.57 13.10%
Expenses 120.97 108.57 11.42% 124.33 107.74 15.40% 142.72 117.87 21.08% 101.15 89.04 13.60%
EBITDA 26.95 24.52 9.91% 24.51 24.50 0.04% 11.76 16.03 -26.64% 21.64 19.54 10.75%
EBIDTM 18.22% 18.43% 16.47% 18.53% 7.61% 11.97% 17.62% 17.99%
Other Income 1.65 2.61 -36.78% 0.88 0.85 3.53% 13.57 6.45 110.39% 2.37 0.80 196.25%
Interest 5.56 7.88 -29.44% 5.23 8.44 -38.03% 6.08 6.01 1.16% 5.51 6.65 -17.14%
Depreciation 7.08 6.81 3.96% 5.64 6.73 -16.20% 7.53 7.30 3.15% 6.85 7.35 -6.80%
PBT 15.96 12.45 28.19% 14.53 10.18 42.73% 11.72 -35.15 - 11.65 6.33 84.04%
Tax 3.51 4.10 -14.39% 2.35 2.16 8.80% 0.13 -3.15 - -3.31 0.80 -
PAT 12.45 8.34 49.28% 12.18 8.03 51.68% 11.59 -32.00 - 14.97 5.52 171.20%
PATM 8.42% 6.27% 8.18% 6.07% 7.50% -23.90% 12.19% 5.09%
EPS 3.94 2.64 49.24% 3.85 2.54 51.57% 3.67 -10.13 - 4.74 1.75 170.86%

Description Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 574.02 542.60 473.42 645.80 679.89 656.98 410.01 325.02 289.51 207.24 200.23 Net Sales Growth 13.04% 14.61% -26.69% -5.01% 3.49% 60.24% 26.15% 12.27% 39.70% 3.50% Cost Of Goods Sold 309.08 286.45 254.77 382.78 406.14 377.89 263.23 196.87 177.68 111.23 105.65 Gross Profit 264.94 256.16 218.65 263.01 273.75 279.09 146.78 128.15 111.83 96.01 94.57 GP Margin 46.16% 47.21% 46.19% 40.73% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% 47.23% Total Expenditure 489.17 460.03 397.08 534.32 561.23 520.62 361.73 282.09 250.08 176.40 170.18 Power & Fuel Cost - 22.77 31.47 37.69 31.83 24.96 24.24 21.83 19.81 16.79 14.12 % Of Sales - 4.20% 6.65% 5.84% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% 7.05% Employee Cost - 57.06 43.85 42.32 41.11 34.55 28.18 24.62 21.65 19.57 16.93 % Of Sales - 10.52% 9.26% 6.55% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% 8.46% Manufacturing Exp. - 59.37 38.89 34.11 59.68 64.02 28.56 25.07 21.53 19.89 23.16 % Of Sales - 10.94% 8.21% 5.28% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% 11.57% General & Admin Exp. - 12.30 10.55 11.08 12.74 11.03 7.95 6.64 5.06 5.76 5.87 % Of Sales - 2.27% 2.23% 1.72% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% 2.93% Selling & Distn. Exp. - 18.90 14.57 19.09 3.91 4.17 1.28 1.77 1.64 1.26 1.17 % Of Sales - 3.48% 3.08% 2.96% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% 0.58% Miscellaneous Exp. - 3.17 2.99 7.25 5.81 4.00 8.28 5.29 2.70 1.90 1.17 % Of Sales - 0.58% 0.63% 1.12% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% 1.64% EBITDA 84.86 82.57 76.34 111.48 118.66 136.36 48.28 42.93 39.43 30.84 30.05 EBITDA Margin 14.78% 15.22% 16.13% 17.26% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% 15.01% Other Income 18.47 19.40 8.69 1.59 1.44 6.91 6.53 0.97 2.07 2.39 0.38 Interest 22.38 28.06 29.75 17.68 12.78 8.34 6.63 8.32 7.73 8.20 7.64 Depreciation 27.10 27.92 27.62 17.21 17.64 16.12 12.12 11.41 11.08 11.35 9.29 PBT 53.86 46.01 27.65 78.18 89.68 118.82 36.06 24.17 22.68 13.69 13.50 Tax 2.68 3.08 -2.35 14.65 18.30 35.71 10.82 7.86 7.50 5.87 5.30 Tax Rate 4.98% 6.69% 14.09% 18.74% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% 39.26% PAT 51.19 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 PAT before Minority Interest 51.19 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.92% 7.91% -3.03% 9.84% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% 4.10% PAT Growth 606.33% - - -11.01% -14.10% 229.28% 54.75% 7.37% 94.25% -4.63% EPS 16.20 13.59 -4.53 20.10 22.59 26.30 7.99 5.16 4.81 2.47 2.59

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 466.16 278.36 367.69 328.49 258.41 177.93 129.11 113.61 99.00 88.63 Share Capital 15.79 13.80 13.80 13.80 13.80 13.80 6.90 6.90 6.90 6.75 Total Reserves 432.80 264.56 353.89 314.69 244.61 164.13 122.21 106.71 92.10 81.88 Non-Current Liabilities 51.00 23.43 96.37 70.54 84.65 27.40 20.41 23.45 27.69 32.26 Secured Loans 64.67 38.58 93.66 66.31 79.71 22.97 16.19 19.80 24.41 27.45 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.60 1.20 1.68 2.43 4.00 Long Term Provisions 4.98 6.14 1.45 2.67 2.78 2.08 1.42 0.77 0.00 0.00 Current Liabilities 272.27 402.11 435.23 322.07 182.57 137.61 117.34 131.07 92.55 88.13 Trade Payables 95.47 89.43 84.75 104.92 68.95 57.48 29.98 43.38 18.85 16.17 Other Current Liabilities 41.69 51.07 47.55 31.44 24.98 21.18 25.62 25.93 20.02 20.06 Short Term Borrowings 133.84 261.48 289.42 176.20 88.47 58.43 54.89 54.52 39.16 42.29 Short Term Provisions 1.26 0.12 13.51 9.51 0.18 0.52 6.84 7.25 14.52 9.60 Total Liabilities 789.43 703.90 899.29 721.10 525.63 342.94 266.86 268.13 219.24 209.02 Net Block 238.45 252.75 365.69 269.74 208.13 162.24 128.50 126.62 127.93 129.56 Gross Block 436.47 422.98 525.01 401.73 329.25 267.83 222.23 209.65 199.88 191.39 Accumulated Depreciation 198.02 170.23 159.32 131.99 121.13 105.59 93.74 83.03 71.95 61.83 Non Current Assets 253.24 263.22 397.26 322.79 267.30 174.53 129.68 128.59 128.16 131.02 Capital Work in Progress 3.45 6.62 21.73 51.98 57.05 5.45 1.18 1.97 0.23 1.46 Non Current Investment 0.00 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 5.73 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 5.61 2.70 9.84 1.07 2.12 1.84 0.00 0.00 0.00 0.00 Current Assets 485.40 404.54 502.04 398.31 258.33 168.42 137.17 139.55 91.08 78.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 161.89 144.04 208.79 159.26 97.11 39.28 30.05 33.66 16.76 19.64 Sundry Debtors 251.67 180.24 194.17 184.51 98.88 98.48 78.13 80.38 52.69 42.95 Cash & Bank 4.45 2.93 19.23 1.98 14.24 4.16 7.86 8.29 0.84 0.36 Other Current Assets 67.39 37.28 35.58 37.59 48.10 26.50 21.13 17.21 20.79 15.04 Short Term Loans & Adv. 31.90 40.06 44.27 14.97 16.10 13.13 18.79 14.98 18.19 12.84 Net Current Assets 213.14 2.43 66.80 76.24 75.76 30.80 19.83 8.47 -1.47 -10.13 Total Assets 738.64 667.76 899.30 721.10 525.63 342.95 266.85 268.14 219.24 209.02

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 21.62 92.29 -22.19 0.69 43.56 20.57 25.17 16.61 22.12 25.14 PBT 42.00 -103.87 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 Adjustment 46.42 169.79 55.89 31.47 24.48 15.54 20.06 18.77 19.32 16.83 Changes in Working Capital -62.21 39.15 -124.76 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 -0.31 Cash after chg. in Working capital 26.21 105.08 -10.66 10.32 79.21 29.70 38.19 22.58 27.20 30.03 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -4.59 -12.79 -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 -4.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -14.82 -11.24 -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 -30.67 Net Fixed Assets -10.32 117.14 -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 -29.87 Net Investments 0.00 0.00 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 0.00 Others -4.50 -128.38 -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 -0.80 Cash from Financing Activity -6.38 -96.60 131.37 61.85 75.46 3.28 -12.57 2.47 -13.20 5.08 Net Cash Inflow / Outflow 0.43 -15.55 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 -0.44 Opening Cash & Equivalents 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 Closing Cash & Equivalent 2.60 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.42

Financial Ratios

Standalone

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 142.04 100.86 133.23 119.02 93.63 64.47 64.41 52.73 71.74 34.33 ROA 5.51% -1.74% 7.84% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% 4.12% ROE 11.81% -4.44% 18.25% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% 19.60% ROCE 11.40% 1.88% 14.02% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% 18.00% Fixed Asset Turnover 1.26 1.00 2.79 1.86 2.20 1.67 1.71 1.60 1.18 1.26 Receivable days 145.27 144.33 53.51 76.07 54.82 78.61 78.15 74.24 75.67 77.37 Inventory Days 102.90 136.01 52.00 68.82 37.89 30.86 31.41 28.13 28.80 30.89 Payable days 117.80 124.77 90.43 78.13 61.06 43.87 46.86 44.67 35.97 41.39 Cash Conversion Cycle 130.36 155.57 15.08 66.76 31.65 65.59 62.70 57.71 68.50 66.87 Total Debt/Equity 0.50 1.19 1.13 0.78 0.70 0.51 0.91 1.19 0.76 1.75 Interest Cover 2.64 0.44 5.42 8.02 15.25 6.44 3.91 3.93 2.67 2.77

Top Investors:

vanaja sundar iyer

hdfc mutual fund - hdfc pharma and healthcare fund

weststone management consultancy pvt ltd

emerging business fund

Annual Reports:

News Update:

Bajaj Healthcare gets nod to conduct Clinical Trial, Bioequivalence Study of Suvorexant Tablets
1st Jan 2026, 11:00 AM

The company has received approval from Central Drugs Standard Control Organisation
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback